Medplus Health Services

Medplus Health Services

832.50
-9.05
(-1.08%)
Market Cap
9,964.51 Cr
EPS
12.57
PE Ratio
56.47
Dividend Yield
0.00 %
Industry
Retail
52 Week High
1,045.30
52 Week Low
634.80
PB Ratio
5.78
Debt to Equity
0.64
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from6 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
MedPlus Reports 11.9% Revenue Growth with Private Label Sales Reaching 18.4% Share1 day ago
MedPlus Health Services reported consolidated revenue of Rs. 15,762 million for the quarter ended September 30, 2024, representing 11.9% year-on-year growth and 5.9% quarter-on-quarter growth. The company operates 4,552 pharmacy stores across 680 cities in 12 states, adding a net 108 stores during the quarter. Private label sales constituted 18.4% of total revenue, with pharmacy private label at 16.3% on GMV basis compared to 7.9% before the launch. Consolidated operating EBITDA stood at Rs. 739 million, representing 4.7% margin. Stores older than 12 months achieved 10.2% store-level EBITDA margin and 58.1% operating ROC. The diagnostic segment recorded revenue of Rs. 283.1 million with 7.4% operating EBITDA margin. Management expects private label contribution to grow by 1-1.25% quarterly on MRP basis and anticipates net store additions of 400-450 stores for the full year, down from earlier guidance of 600 stores due to slower first quarter openings.
negative
Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services Limited, received a two-day suspension order for its drug license at a store located in Boduppal Brundavan Colony, Telangana. The suspension was issued by the Assistant Director of Drugs Control Administration, Shameerpet, Telangana, due to violations under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company estimates a potential revenue loss of approximately Rs. 0.81 lacs from this suspension.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
832.50
#1 9,964.51
#2 56.47
#1 6,184.70
#1 23.05
#1 150
#1 195.80
47.38
1,203.30
5,235.43
#1 50.11
5,135.30
19.09
107
47.32
42.68
39.00
59.21
-
9.20
-4.17
-2
-166.67
45.44

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
23.05 %
Net Income Growth
30.94 %
Cash Flow Change
275.98 %
ROE
23.81 %
ROCE
22.10 %
EBITDA Margin (Avg.)
2.81 %

Quarterly Financial Results

Quarterly Financials
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
810
810
959
932
941
979
1,004
1,132
1,202
1,267
1,294
1,419
1,451
1,501
1,498
1,588
1,574
1,525
1,558
Expenses
743
745
859
863
872
914
941
1,061
1,119
1,171
1,213
1,324
1,350
1,385
1,395
1,452
1,429
1,373
1,412
EBITDA
67
65
101
69
69
65
63
71
83
95
81
96
102
116
103
136
145
152
146
Operating Profit %
7 %
7 %
10 %
7 %
7 %
5 %
5 %
5 %
6 %
7 %
6 %
6 %
6 %
7 %
6 %
8 %
8 %
9 %
8 %
Depreciation
22
24
27
28
31
34
38
42
46
56
52
56
57
59
60
63
63
64
66
Interest
13
15
15
16
17
19
20
20
21
22
23
24
25
25
25
25
26
27
27
Profit Before Tax
32
26
58
25
22
13
5
9
16
17
5
16
20
32
18
48
57
61
53
Tax
9
8
12
5
5
1
1
2
3
-9
1
2
6
-2
4
9
11
10
10
Net Profit
23
18
46
20
17
11
4
7
13
27
4
15
14
34
14
39
46
51
42
EPS in ₹
2.21
1.76
4.34
1.85
1.53
0.99
0.27
0.55
1.12
2.24
0.32
1.22
1.15
2.81
1.20
3.24
3.84
4.32
3.54

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
438
509
538
644
673
1,349
1,566
2,594
2,797
3,005
3,360
Fixed Assets
67
77
81
84
90
420
517
799
1,138
1,242
1,296
Current Assets
317
376
397
458
475
816
923
1,632
1,481
1,568
1,844
Capital Work in Progress
3
4
0
1
1
5
6
20
26
11
16
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
368
429
457
560
582
924
1,043
1,775
1,633
1,752
2,047
Total Liabilities
438
509
538
644
673
1,349
1,566
2,594
2,797
3,005
3,360
Current Liabilities
210
269
278
326
337
481
415
559
477
526
577
Non Current Liabilities
74
91
111
15
11
339
420
618
830
902
1,044
Total Equity
154
150
149
304
325
529
731
1,417
1,491
1,577
1,740
Reserve & Surplus
141
137
149
303
325
528
359
1,394
1,467
1,554
1,717
Share Capital
12
12
0
0
0
0
0
24
24
24
24

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
32
-15
-10
14
45
56
-37
-93
350
-137
-5
Investing Activities
-16
-32
-15
-18
-19
-28
-35
-703
429
-83
-318
Operating Activities
-19
-17
34
32
147
-7
3
170
90
144
540
Financing Activities
67
35
-29
-1
-83
90
-6
440
-170
-198
-228

Share Holding

% Holding
Aug 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
96.68 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.43 %
40.41 %
40.45 %
40.39 %
40.39 %
40.39 %
40.39 %
40.34 %
40.32 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
12.36 %
0.00 %
14.94 %
14.85 %
14.72 %
15.23 %
15.61 %
16.42 %
DIIs
0.00 %
11.61 %
11.99 %
14.96 %
14.31 %
28.77 %
28.16 %
13.62 %
25.49 %
16.28 %
22.47 %
22.17 %
27.97 %
25.65 %
26.19 %
26.04 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
6.38 %
5.83 %
5.88 %
6.22 %
6.21 %
6.13 %
5.83 %
6.40 %
6.15 %
7.30 %
7.56 %
11.84 %
13.21 %
13.10 %
12.59 %
Others
3.32 %
41.58 %
41.75 %
38.73 %
39.05 %
24.59 %
25.28 %
40.12 %
15.33 %
37.12 %
14.90 %
15.03 %
5.07 %
5.52 %
4.77 %
4.64 %
No of Share Holders
69
3,42,917
82,627
77,119
76,972
74,702
73,512
70,017
66,430
66,048
74,976
76,934
87,328
83,912
83,439
81,742

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
15 Sept 2025 915.25 832.75
15 Dec 2023 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
15 Dec 2023 813.50 734.65
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 682.10 689.45
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 650.80 674.95
31 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jan 2025 847.90 730.65
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 732.15 977.00
02 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Aug 2025 853.60 915.25

Announcements

Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20151 day ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20152 days ago
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 23, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 23, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 22, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 21, 2025
Reg. 34 (1) Annual Report.Aug 21, 2025
Notice Of 19Th Annual General Meeting Of The Company For The Financial Year 2024-25Aug 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 21, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 19, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 15, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 14, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 13, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 07, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 03, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 02, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 02, 2025
Un-Audited Financial Results For The Quarter Ended June 30 2025Aug 02, 2025
Board Meeting Outcome for Board Meeting Outcome For Meeting Held On August 02 2025Aug 02, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 02, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 31, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 28, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 26, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 23, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 22, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 19, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 18, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 16, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 15, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jul 12, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 11, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 10, 2025
Board Meeting Intimation for Consider & Approve Un-Audited Financial Result For Quarter Ended June 30 2025Jul 09, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 09, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 08, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Jul 06, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 03, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 01, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 28, 2025
Closure of Trading WindowJun 27, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 24, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 22, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 20, 2025
Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 19, 2025

Technical Indicators

RSI(14)
Neutral
44.32
ATR(14)
Less Volatile
26.15
STOCH(9,6)
Neutral
63.92
STOCH RSI(14)
Neutral
78.73
MACD(12,26)
Bullish
2.80
ADX(14)
Weak Trend
18.94
UO(9)
Bearish
44.99
ROC(12)
Downtrend And Accelerating
-0.30
WillR(14)
Neutral
-47.37

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Nippon India Pharma Fund Direct-Growth
0.00%
-3627277
-3.86%
-3.83%
Kotak Small Cap Fund Direct-Growth
0.00%
-3578425
-1.86%
-1.80%
Nippon India Multi Cap Fund Direct-Growth
0.00%
-2527912
-0.51%
-0.50%
Franklin India Small Cap Fund Direct-Growth
0.00%
-2432539
-1.64%
-1.57%
Nippon India Focused Fund Direct-Growth
0.00%
-2098553
-2.27%
-2.16%
SBI ELSS Tax Saver Fund Direct-Growth
0.00%
-1723010
-0.53%
-0.51%
Invesco India Large & Mid Cap Fund Direct-Growth
0.00%
-1154182
-1.34%
-1.32%
Franklin India Flexi Cap Fund Direct-Growth
0.00%
-1132626
-0.56%
-0.53%
Invesco India Contra Fund Direct-Growth
0.00%
-1094617
-0.53%
-0.51%
Invesco India Mid Cap Fund Direct-Growth
0.00%
-1050416
-1.25%
-1.28%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.00%
-937074
-1.43%
-1.48%
ICICI Prudential India Opportunities Fund Direct - Growth
0.00%
-715753
-0.22%
-0.22%
Nippon India Flexi Cap Fund Direct - Growth
0.00%
-450000
-0.46%
-0.44%
Bandhan Small Cap Fund Direct-Growth
0.00%
-394694
-0.26%
-0.28%
Kotak Pioneer Fund Direct - Growth
0.00%
-393797
-1.21%
-1.20%
Bandhan Innovation Fund Direct-Growth
0.00%
-316858
-1.75%
-1.78%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.00%
-241203
-0.87%
-0.83%
Tata India Innovation Fund Direct-Growth
0.00%
-228120
-1.22%
-1.38%
Quant Consumption Fund Direct - Growth
0.00%
-208127
-7.81%
-7.08%
DSP Healthcare Fund Direct - Growth
0.00%
-192078
-0.56%
-0.57%
Kotak Business Cycle Fund Direct - Growth
0.00%
-191964
-0.63%
-0.61%
Nippon India Multi Asset Allocation Fund Direct - Growth
0.00%
-182368
-0.26%
-0.26%
Nippon India Aggressive Hybrid Fund Direct-Growth
0.00%
-169000
-0.40%
-0.38%
Bandhan Balanced Advantage Fund Direct-Growth
0.00%
-144871
-0.59%
-0.57%
Franklin India ELSS Tax Saver Fund Direct-Growth
0.00%
-122459
-0.17%
-0.16%